Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during...

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Premature infants often experience respiratory issues, leading to the use of glucocorticoid (GC) therapy to mature lungs.
• GC therapy, while beneficial for respiratory function, is linked to neurodevelopmental deficits, particularly cerebellar stunting.

Purpose of the Study:

• To investigate the mechanisms by which GC therapy may induce neurodevelopmental deficits in the cerebellum.
• To review rodent and human research on GC-induced cerebellar apoptosis and its impact on neuronal development.

Main Methods:

• Review of existing rodent and human research studies.
• Analysis of the role of the cerebellar external granule layer (EGL) in neuronal development.
• Examination of the effects of endogenous and exogenous GC stimulation on the EGL.

Main Results:

• GC therapy may trigger rapid apoptosis in the cerebellar EGL, a critical region for neuron production.
• This precocious elimination of the EGL can occur before sufficient neuron generation, potentially impairing cerebellar function.
• Endogenous GCs play a role in normal EGL development, but therapeutic levels may disrupt this process.

Conclusions:

• GC therapy might disrupt cerebellar development by inducing premature apoptosis in the EGL.
• This mechanism offers a potential explanation for the observed neurodevelopmental deficits associated with GC treatment.
• Findings may inform future clinical research and guide safer therapeutic strategies for GC use in neonates.